Tiny delivery system with a big impact on cancer cells

Researchers in Pennsylvania are reporting for the first time that nanoparticles 1/5,000 the diameter of a human hair encapsulating an experimental anticancer agent, kill human melanoma and drug-resistant breast cancer cells growing in laboratory cultures. The discovery could lead to the development of a new generation of anti-cancer drugs that are safer and more effective than conventional chemotherapy agents, the scientists suggest. The research is scheduled for the Dec. 10 issue of ACS' Nano Letters.

If you want to include this story in your blog, copy and paste this formatted text: